GDF-15 (Growth Differentiation Factor 15) Is Associated With Lack of Ventricular Recovery and Mortality After Transcatheter Aortic Valve Replacement [Structural Heart Disease]

Conclusions— Elevated GDF-15 correlates with lack of reverse remodeling and increased mortality after TAVR and improves risk prediction of mortality when added to the Society of Thoracic Surgeons score.

http://circinterventions.ahajournals.org/cgi/content/short/10/12/e005594?rss=1

Source: Circulation: Cardiovascular Interventions - December 8, 2017 Category: Cardiology Authors: Kim, J. B., Kobayashi, Y., Moneghetti, K. J., Brenner, D. A., OMalley, R., Schnittger, I., Wu, J. C., Murtagh, G., Beshiri, A., Fischbein, M., Miller, D. C., Liang, D., Yeung, A. C., Haddad, F., Fearon, W. F. Tags: Biomarkers, Translational Studies, Valvular Heart Disease, Aortic Valve Replacement/Transcatheter Aortic Valve Implantation Structural Heart Disease Source Type: research